Clinical Trial Update: Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial update of cladribine, cytarabine, and imatinib mesylate in refractory or relapsed acute myeloid leukemia or blastic phase chronic myeloid leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Cladribine (cladribine)
• Imatinib mesylate (Imatinib)

Snippet

Sponsor: University of Rochester | Conditions: Leukemia | Phase 1 | Status: COMPLETED